| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.18B | 17.65B | 18.13B | 17.51B | 16.79B | 15.85B |
| Gross Profit | 7.59B | 7.52B | 7.62B | 7.13B | 6.45B | 5.50B |
| EBITDA | 1.48B | 1.17B | 2.10B | 1.62B | 1.26B | 1.43B |
| Net Income | 706.00M | 10.12B | 1.37B | 764.00M | 878.00M | 773.00M |
Balance Sheet | ||||||
| Total Assets | 29.56B | 42.17B | 29.96B | 28.70B | 27.32B | 26.67B |
| Cash, Cash Equivalents and Short-Term Investments | 10.21B | 25.38B | 10.65B | 9.51B | 10.35B | 8.78B |
| Total Debt | 318.00M | 0.00 | 222.00M | 66.00M | 40.00M | 5.00M |
| Total Liabilities | 5.14B | 8.74B | 5.35B | 5.15B | 4.91B | 5.43B |
| Stockholders Equity | 23.55B | 33.43B | 23.68B | 22.67B | 21.58B | 20.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.00M | 1.21B | -2.09B | 784.00M | 343.00M |
| Operating Cash Flow | 0.00 | 123.00M | 1.32B | 1.09B | 1.16B | 671.00M |
| Investing Cash Flow | 0.00 | 16.39B | 312.00M | -1.77B | 540.00M | -191.00M |
| Financing Cash Flow | 0.00 | -2.04B | -458.00M | -454.00M | -266.00M | -214.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥897.35B | 10.71 | 7.77% | 3.16% | 1.93% | 25.12% | |
79 Outperform | ¥848.29B | 14.35 | 10.50% | 2.03% | 3.03% | 26.77% | |
75 Outperform | ¥3.79T | 12.90 | 7.81% | 2.07% | 5.04% | 5.98% | |
70 Outperform | ¥34.56B | 0.89 | ― | 4.37% | -2.63% | 635.00% | |
67 Neutral | ¥821.48B | 13.43 | 6.04% | 2.78% | 3.18% | 24.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥291.75B | 7.18 | -12.69% | 0.71% | -3.56% | ― |